TMC-ACTREC Cancer Project JRF Job – Attend Walk-In-Interview
TATA MEMORIAL CENTRE
ADVANCED CENTRE FOR TREATMENT, RESEARCH
AND EDUCATION IN CANCER
Kharghar, Navi Mumbai- 410 210
www.actrec.gov.in
Phone No: 91-22-27405000/5082/5353
(A Grant-in-aid Institution of the Dept. of Atomic Energy, Government of India)
No. ACTREC/ADVT-20/2024
Date: 23.02.2024
INTERVIEW FOR JUNIOR RESEARCH FELLOW (ON PROJECT)
“Crosstalk between gamma-delta T cells and tumor associated macrophages in governing immunosuppression in ovarian cancer”-Cancer Immune-environment and Therapeutics Lab Principal Investigator: Dr. Subir Biswas
EDUCATIONAL QUALIFICATION & EXPERIENCE: MSc/MTech in Biotechnology, Microbiology, Molecular Biology with any national level examination (NET, ICMR, DBT, GATE etc.) qualified.
Experience: Candidates with previous hands-on experience working with animal models and/or mammalian cell culture, and flow cytometry for at least six months, will be given preference. M.Sc. degree having duration of one-year course will not be considered. Selected candidate will have to join at the earliest; hence result-awaited candidates will not be eligible to apply for the post.
CONSOLIDATED SALARY: Rs. 38,440/- per month. (Rs. 31,000/-+24%HRA) p.m.
DURATION: Six months, extendable up to 2 years. The work progress of the candidate will be monitored and extension after 6 months.
How to Apply:
Eligible Candidates may attend the walk-in interview on Friday, 15th March, 2024
in Meeting Room II, 3rd Floor, Khanolkar Shodhika, ACTREC along with a recent CV, original and attested copies of all certificates and testimonials with a recent passport size photograph and ID proof.Reporting Time: 01:30 pm to 02:00 pm.
Keywords: TMC-ACTREC, Mol Bio, Research Fellow, Recruitment, Cancer, Immunotherapy, Mumbai. TMC-ACTREC Cancer Project JRF Job – Attend Walk-In-Interview. Please ensure you are subscribed to the Biotecnika Times Newsletter and our YouTube channel to be notified of the latest industry news. Follow us on social media like Twitter, Telegram, Facebook
